DK2412368T3
(en )
2013-11-04
Composition for the treatment of scars
DK1147083T3
(en )
2004-08-16
Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
DK1144395T3
(en )
2005-08-15
2-amino-benzoxazinone derivatives for the treatment of obesity
DK1077940T3
(en )
2004-11-01
4-Phenylpiperidines for the treatment of pruritic dermatoses
DK1292594T3
(en )
2004-12-06
Quinazoline derivatives for the treatment of tumors
DK1259512T3
(en )
2003-12-29
Pteridine compounds for the treatment of psoreasis
DK1064298T3
(en )
2009-01-19
Inhibitors of caspases
DK1063990T3
(en )
2007-05-21
Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
DK1371647T3
(en )
2005-10-17
Pyrazolopyrimidinone cGMP PDE5 Inhibitors for the Treatment of Sexual Disorder
DK0830864T3
(en )
2003-05-26
Combination therapy for the treatment of psychoses
DK1112106T3
(en )
2005-12-12
Serotonergic 5HT2 agonists for the treatment of glaucoma
DK1562932T3
(en )
2007-08-13
4 tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DE60019555D1
(en )
2005-05-25
2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DE50010774D1
(en )
2005-08-25
APPENDIX FOR THE MACHINING OF WAFERN
DK1282616T3
(en )
2004-09-20
Hydroxyphenylpiperidin-4-ylidene methylbenzamide derivatives for the treatment of pain
DE50013866D1
(en )
2007-01-25
APPENDIX FOR THE MACHINING OF WAFERN
DK1176964T3
(en )
2007-01-15
Use of ET743 for the treatment of cancer
DK1206436T3
(en )
2005-02-14
Retinoids for the treatment of emphysema
DK1392318T3
(en )
2007-06-25
15-keto-prostaglandins for the treatment of drug-induced constipation
DE50013163D1
(en )
2006-08-24
APPENDIX FOR THE MACHINING OF WAFERN
DK0965566T3
(en )
2006-11-06
Process for the treatment of organic wastewater
DK199800837A
(en )
1999-12-30
Installations for the treatment of subjects
ID27214A
(en )
2001-03-08
TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
DK1008558T3
(en )
2004-09-06
Process for the treatment of organic wastewater
DK1054868T3
(en )
2003-12-22
Substituted pyridinoarylpiperazines suitable for the treatment of prostate hyperplasia